TG Therapeutics Inc (TGTX) — Cash Flow Reinvestment Rate
Latest as of December 2025:
0.86x
TG Therapeutics Inc (TGTX) has a Cash Flow Reinvestment Rate of 0.86x as of December 2025, reinvesting $16.89 Million (capex $67.00K plus investments $-16.82 Million) from operating cash flow of $19.66 Million. Check TGTX cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.86x
(Capex + Investments) / Operating CF
Total Reinvested
$16.89 Million
Capex + Investments
Operating Cash Flow
$19.66 Million
USD
Capital Expenditures
$67.00K
USD
Annual Cash Flow Reinvestment Rate for TG Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for TG Therapeutics Inc. For live market cap and broader valuation context, see TG Therapeutics Inc stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow